Relationships among symptoms, bother, and treatment satisfaction in overactive bladder patients

Neurourology and Urodynamics

Volumn 26, Issue 2, 2007, Pages 190-195

  Michel, Martin C ^a,e   Oelke, Matthias ^a   Goepel, Mark ^b   Beck, Elmar ^c   Burkart, Martin ^d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Klinikum Niederberg   (Germany)

^c Anfomed GmbH   (Germany)

^d PFIZER INC   (United States)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bother; Factor analysis; Overactive bladder; Symptom scales; Tolterodine; Treatment satisfaction

Indexed keywords

TOLTERODINE;

ADULT; AGED; ARTICLE; DAILY LIFE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOCTURIA; OVERACTIVE BLADDER; PATIENT PERCEPTION OF BLADDER CONDITION SCALE; PATIENT SATISFACTION; RATING SCALE; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME; URGENCY PERCEPTION SCALE; URINARY FREQUENCY; URINARY URGENCY; URINE INCONTINENCE; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; BENZHYDRYL COMPOUNDS; CLUSTER ANALYSIS; CRESOLS; DELAYED-ACTION PREPARATIONS; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; NOCTURIA; PATIENT SATISFACTION; PHENYLPROPANOLAMINE; PRINCIPAL COMPONENT ANALYSIS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

EID: 34247146370     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20367     Document Type: Article

References (24)

1. Abrams P, Cardozo L, Fall M, et al. 2002.The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21:167-78.
2. Barry MJ, Williford WO, Fowler FJ, jr., et al. 2000. Filling and voiding symptoms in the American Urological Association Symptom Score index: The value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia. J Urol 164:1559-64.
3. Berner MM, Burkart M. 2006. Contribution of sex to partnership and self-esteem in different types of men. J Sex Med 3 (Suppl. 3):201-2.
4. Brady CM, Apostolidis AN, Harper M, et al. 2005. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment. BJU Int 93:770-6.
5. Brookes ST, Donovan JL, Wright M, et al. 2004. A scored form of the Bristol Female Lower Urinary Tract Symptom questionnaire: Data from a randomized controlled trial of surgery for women with stress incontinence. Am J Obstet Gynecol 191:73-82.
6. Cardozo L, Dixon A. 2005. Increased warning time with darifenacin: A new concept in the management of urinary urgency. J Urol 173:1214-8.
7. Cardozo L, Coyne KS, Versi E. 2005. Validation of the urgency perception scale. BJU Int 95:591-6.
8. Chapple CR, Artibani W, Cardozo LD, et al. 2005. The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: Current concepts and future prospects. BJU Int 95:335-40.
9. Coyne K, Revicki D, Hunt T, et al. 2002. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-q. Quality Life Res 11:563-74.
10. Freeman R, Hill S, Millard R, et al. 2003. Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine. Obstet Gynecol 102:605-11.
11. Herbison P, Hay-Smith J, Ellis G, et al. 2003. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: Systematic review. Br Med J 326:841-4.
12. Khullar V, Hill S, Laval K-U, et al. 2004a. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: A randomized, placebo-controlled trial. Urology 64:269-75.
13. Khullar V, Hill S, Solanki J, et al. 2004b. Tolterodine increases the urgency-free time interval: A sensory or motor effect? http://www continet org/ publications/2004/PDF/0172 PDF accessed 23-11-2005b.
14. Landis JR, Kaplan S, Swift S, et al. 2004. Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity. J Urol 171:752-6.
15. Lukacz ES, Lawrence JM, Burchette RJ, et al. 2004. The use of Visual Analog Scale in urogynecologic research: A psychometric evaluation. Am J Obstet Gynecol 191:165-70.
16. Matza LS, Thompson CL, Krasnow J, et al. 2005. Test-retest reliability of four questionnaires for patients with overactive bladder: The overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ). Neurourol Urodyn 24:215-25.
17. Michel MC, de la Rosette JJMCH. 2005. Role of muscarinic receptor antagonists in urgency and nocturia. BJU Int 96:37-42.
18. Michel MC, de la Rosette JJMCH, Piro M, et al. 2005. Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder. Eur Urol 48:110-5.
19. Milsom I, Abrams P, Cardozo L, et al. 2001. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87:760-6.
20. Nochajski TH, Burns PA, Pranikoff K, et al. 1993. Dimensions of urine loss among older women with genuine stress incontinence. Neurourol Urodyn 12:223-33.
21. Rackley R, Weiss JP, Rovner ES, et al. 2006. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology 67:731-6.
22. Rosen RC, Riley A, Wagner G, et al. 1997. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 49:822-30.
23. Stewart WF, van Rooyen JB, Cundiff GW, et al. 2003. Prevalence and burden of overactive bladder in the United States. World J Urol 20:327-36.
24. Zinner N, Harnett M, Sabounjian L, et al. 2005. The overactive bladder-symptom composite score: A composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladder. J Urol 173:1639-43.